GSK2646264

Modify Date: 2024-01-02 12:36:56

GSK2646264 Structure
GSK2646264 structure
Common Name GSK2646264
CAS Number 1398695-47-0 Molecular Weight 374.48
Density 1.1±0.1 g/cm3 Boiling Point 517.4±50.0 °C at 760 mmHg
Molecular Formula C24H26N2O2 Melting Point N/A
MSDS N/A Flash Point 266.7±30.1 °C

 Use of GSK2646264


GSK2646264 (Compound 44) is a potent and selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.1. GSK2646264 also inhibits other kinases with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3 against LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B and Aurora A, respectively. GSK2646264 is penetrable into the epidermis and dermis of the skin[1].

 Names

Name GSK2646264
Synonym More Synonyms

 GSK2646264 Biological Activity

Description GSK2646264 (Compound 44) is a potent and selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.1. GSK2646264 also inhibits other kinases with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3 against LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B and Aurora A, respectively. GSK2646264 is penetrable into the epidermis and dermis of the skin[1].
Related Catalog
Target

SYK:7.1 (pIC50)

LCK:5.4 (pIC50)

LRRK2:5.4 (pIC50)

GSK3β:5.3 (pIC50)

JAK2:5 (pIC50)

VEGFR2:4.5 (pIC50)

Aurora B:<4.6 (pIC50)

Aurora A:<4.3 (pIC50)

References

[1]. Barker MD, et al. Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease. Bioorg Med Chem Lett. 2018 Nov 15;28(21):3458-3462.

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 517.4±50.0 °C at 760 mmHg
Molecular Formula C24H26N2O2
Molecular Weight 374.48
Flash Point 266.7±30.1 °C
Exact Mass 374.199432
LogP 3.40
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.585

 Synonyms

7-{2-Methoxy-6-[(4-methyl-2-pyridinyl)methoxy]phenyl}-2,3,4,5-tetrahydro-1H-3-benzazepine
1H-3-Benzazepine, 2,3,4,5-tetrahydro-7-[2-methoxy-6-[(4-methyl-2-pyridinyl)methoxy]phenyl]-